These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 28476527)

  • 21. Genetic variants in a long noncoding RNA related to Sunitinib Resistance predict risk and survival of patients with renal cell carcinoma.
    Xing Q; Li R; Xu A; Qin Z; Tang J; Zhang L; Tang M; Han P; Wang W; Qin C; Du M; Zhang W
    Cancer Med; 2019 Jun; 8(6):2886-2896. PubMed ID: 31038847
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The GNAS1 T393C polymorphism predicts survival in patients with clear cell renal cell carcinoma.
    Frey UH; Lümmen G; Jäger T; Jöckel KH; Schmid KW; Rübben H; Müller N; Siffert W; Eisenhardt A
    Clin Cancer Res; 2006 Feb; 12(3 Pt 1):759-63. PubMed ID: 16467086
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Single nucleotide polymorphisms in the hypoxia-inducible factor-1 gene and colorectal cancer risk.
    Knechtel G; Szkandera J; Stotz M; Hofmann G; Langsenlehner U; Krippl P; Samonigg H; Renner W; Langner C; Dehchamani D; Gerger A
    Mol Carcinog; 2010 Sep; 49(9):805-9. PubMed ID: 20572162
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HIF-1α (1772C>T) polymorphism as marker for breast cancer development.
    Meka PB; Cingeetham A; Nanchari SR; Damineni S; Tipirisetti N; Gorre M; Jarjapu S; Annamaneni S; Digumarthi R; Satti V
    Tumour Biol; 2015 May; 36(5):3215-20. PubMed ID: 25510668
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk of renal cell carcinoma and polymorphism in phase I xenobiotic metabolizing CYP1A1 and CYP2D6 enzymes.
    Ahmad ST; Arjumand W; Seth A; Nafees S; Rashid S; Ali N; Hamiza OO; Sultana S
    Urol Oncol; 2013 Oct; 31(7):1350-7. PubMed ID: 22281432
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The bcl2 -938CC genotype has poor prognosis and lower survival in renal cancer.
    Hirata H; Hinoda Y; Nakajima K; Kikuno N; Suehiro Y; Tabatabai ZL; Ishii N; Dahiya R
    J Urol; 2009 Aug; 182(2):721-7. PubMed ID: 19539330
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HIF-1α genetic variants and protein expression confer the susceptibility and prognosis of gliomas.
    Yi L; Hou X; Zhou J; Xu L; Ouyang Q; Liang H; Zheng Z; Chen H; Xu M
    Neuromolecular Med; 2014 Sep; 16(3):578-86. PubMed ID: 24929654
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term outcome of small, organ-confined renal cell carcinoma (RCC) is not always favourable.
    Shindo T; Masumori N; Kobayashi K; Fukuta F; Hirobe M; Tonooka A; Hasegawa T; Kitamura H; Tsukamoto T
    BJU Int; 2013 May; 111(6):941-5. PubMed ID: 23350965
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Single nucleotide polymorphisms and risk of recurrence of renal-cell carcinoma: a cohort study.
    Schutz FA; Pomerantz MM; Gray KP; Atkins MB; Rosenberg JE; Hirsch MS; McDermott DF; Lampron ME; Lee GS; Signoretti S; Kantoff PW; Freedman ML; Choueiri TK
    Lancet Oncol; 2013 Jan; 14(1):81-7. PubMed ID: 23219378
    [TBL] [Abstract][Full Text] [Related]  

  • 30. DNA repair system and renal cell carcinoma prognosis: under the influence of NBS1.
    Rosinha A; Assis J; Dias F; Nogueira A; Pereira D; Maurício J; Teixeira AL; Medeiros R
    Med Oncol; 2015 Nov; 32(11):255. PubMed ID: 26493193
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Leukocyte telomere length and
    Morais M; Dias F; Resende T; Nogueira I; Oliveira J; Maurício J; Teixeira AL; Medeiros R
    Future Oncol; 2020 Jun; 16(18):1245-1255. PubMed ID: 32422075
    [No Abstract]   [Full Text] [Related]  

  • 32. Monocyte chemotactic protein-1 and CC chemokine receptor 2 polymorphisms and prognosis of renal cell carcinoma.
    Liu GX; Zhang X; Li S; Koiiche RD; Sindsceii JH; Song H
    Tumour Biol; 2013 Oct; 34(5):2741-6. PubMed ID: 23657965
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Polymorphisms of HIF1A gene are associated with prognosis of early stage non-small-cell lung cancer patients after surgery.
    Liu B; Liu Q; Song Y; Li X; Wang Y; Wan S; Zhang Z; Su H
    Med Oncol; 2014 Apr; 31(4):877. PubMed ID: 24567056
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lack of association between hypoxia inducible factor-1 alpha gene polymorphisms and biopsy-proven giant cell arteritis.
    Torres O; Palomino-Morales R; Vazquez-Rodriguez TR; Gamallo C; Morado IC; Miranda-Filloy JA; Amigo-Diaz E; Callejas-Rubio JL; Fernadez-Gutierrez B; Castañeda S; Morado IC; Martin J; Gonzalez-Gay MA
    Clin Exp Rheumatol; 2010; 28(1 Suppl 57):40-5. PubMed ID: 20412701
    [TBL] [Abstract][Full Text] [Related]  

  • 35. No association of the hypoxia-inducible factor-1α gene polymorphisms with survival in patients with colorectal cancer.
    Lee SJ; Kim JG; Sohn SK; Chae YS; Moon JH; Kang BW; Park JS; Park JY; Choi GS
    Med Oncol; 2011 Dec; 28(4):1032-7. PubMed ID: 20635169
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Polymorphic variation of hypoxia inducible factor-1 A (HIF1A) gene might contribute to the development of knee osteoarthritis: a pilot study.
    Fernández-Torres J; Hernández-Díaz C; Espinosa-Morales R; Camacho-Galindo J; Galindo-Sevilla Ndel C; López-Macay Á; Zamudio-Cuevas Y; Martínez-Flores K; Santamaría-Olmedo MG; Pineda C; Granados J; Martínez-Nava GA; Gutiérrez M; López-Reyes AG
    BMC Musculoskelet Disord; 2015 Aug; 16():218. PubMed ID: 26293784
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The association of DNA repair gene polymorphisms with the development and progression of renal cell carcinoma.
    Sakano S; Hinoda Y; Okayama N; Kawai Y; Korenaga Y; Eguchi S; Nagao K; Ohmi C; Naito K
    Ann Oncol; 2007 Nov; 18(11):1817-27. PubMed ID: 17712032
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Somatic VHL alteration and its impact on prognosis in patients with clear cell renal cell carcinoma.
    Kim JH; Jung CW; Cho YH; Lee J; Lee SH; Kim HY; Park J; Park JO; Kim K; Kim WS; Park YS; Im YH; Kang WK; Park K
    Oncol Rep; 2005 May; 13(5):859-64. PubMed ID: 15809750
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of survivin (BIRC5) and caspase-9 (CASP9) functional polymorphisms in renal cell carcinoma development: a study in a southern European population.
    Marques I; Teixeira AL; Ferreira M; Assis J; Lobo F; Maurício J; Medeiros R
    Mol Biol Rep; 2013 Aug; 40(8):4819-26. PubMed ID: 23645041
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of a functional polymorphism in the pre-miR-146a gene on the risk and prognosis of renal cell carcinoma.
    Huang Z; Lu Z; Tian J; Wang G; Gao Z
    Mol Med Rep; 2015 Nov; 12(5):6997-7004. PubMed ID: 26323945
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.